It remains a disturbing fact that even though everyone knows what oncology is, very few of know about what it truly entails. But thanks to the oncotarget publication, all aspects of oncology are highlighted on a weekly basis hence disseminating desired knowledge to all the lucky readers. A myriad of oncology subjects has been covered in oncotarget for instance, oleuropein and its health benefits.
Oleuropein is a compound available in olive leaves and oil extracts that have been known for its vigilance in decreasing the chances of a tumor development. In addition to that, the polyphenolic compound can also aid in the treatment of hypertension as it is best known for its blood pressure lowering properties.
Another outstanding hallmark of oncotarget write-ups is that they are imposingly written. The writers fully understand that not everyone is familiar with complicated medical jargon explaining why their articles are comprehensively written in layman language, unless otherwise. Apart from taking the time to explain medical jargon, these oncology-related articles are also very exhaustive.
For instance, on the subject of oleuropein component, the journal goes on to expound on how the polyphenolic compound can be used to treat hypertension. The same is the case with how it treats tumors while highlighting on its anti-inflammatory and antioxidant properties. You won’t also miss out on oleuropein and its anti cancer properties.
Also, expect the oncotarget journal to list the kind of foods that are rich in compounds that will prevent, treat or keep tumors and other age-related infections at bay. Still, on the piece on oleuropein, they have indicated the sources of foods that one can get their constant supply of oleuropein including olive oil and its extracts.
Finally, another benefit of oncotarget is the fact that they keep insisting on consulting with a qualified physician on the regular. The latter is very important because not doing so can have undesired repercussions such as health problems due to negligence. In conclusion, it is important for those who haven’t subscribed to the oncotarget to do so since it is for their benefit.
To know more visit @: https://twitter.com/oncotargetjrnl?lang=en